 |
|
Prediction of Myocardial Infarction in Dyslipidemic Men by Elevated Levels of Immunoglobulin Classes A, E, and G, but Not M
Petri T. Kovanen, MD;
Matti Mänttäri, MD;
Timo Palosuo, MD;
Vesa Manninen, MD;
Kimmo Aho, MD
Arch Intern Med. 1998;158:1434-1439.
Background Immune mechanisms have been suggested to play an important role in the development of coronary atherosclerosis and its thrombotic complications. We evaluated the predictive value of the levels of various serum immunoglobulin classes in middle-aged men at increased risk of myocardial infarction.
Methods Using nested case-control design and logistic regression analysis, we estimated the association between serum immunoglobulins and the risk of coronary end points (nonfatal or fatal myocardial infarction or sudden cardiac death) in dyslipidemic men (levels of non–high-density lipoprotein cholesterol >5.2 mmol/L [>201 mg/dL]) participating in the Helsinki Heart Study. The cases consisted of 135 subjects in whom a coronary end point occurred during the 5-year observation period of the study, and the controls were 135 subjects who did not suffer coronary end points during this period. Levels of IgA, IgE, IgG, and IgM were determined in serum samples collected at study entry.
Results Levels of IgA, IgE, and IgG, but not IgM, were significantly higher in cases than in controls. After adjustment for other risk factors, such as age, smoking, and blood pressure, the risk of coronary disease showed a significant relation to the levels of IgA, IgE, and IgG. The risk in the highest quartile of each distribution as compared with the lowest quartile was 2.2-fold for IgA (95% confidence interval, 1.0-4.5), 2.8-fold for IgE (1.3-5.9), and 2.8-fold for IgG (1.3-5.9). Hypertriglyceridemia and a low level of high-density lipoprotein cholesterol were associated with increased risk of a coronary end point only if the levels of IgA, IgE, or IgG were also elevated.
Conclusion Elevated levels of IgA, IgE, and IgG are associated with myocardial infarction and cardiac death in men with dyslipidemia. The present data suggest that, for dyslipidemia to cause coronary atherothrombosis, an immune response reflected by elevated levels of these immunoglobulin classes is an important determinant.
From the Wihuri Research Institute (Dr Kovanen), Department of Medicine, Helsinki University Central Hospital (Drs Mänttäri and Manninen), and National Public Health Institute (Drs Palosuo and Aho), Helsinki, Finland.
RELATED LETTER
Immunoglobulins, C3, and the Risk of Myocardial Infarction
Antonio Muscari, Paolo Puddu, Petri T. Kovanen, Matti Mänttäri, Timo Palosuo, Vesa Manninen, and Kimmo Aho
Arch Intern Med. 1999;159(19):2364-2365.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Atherosclerosis and the Immune System
Vera Bittner
Arch Intern Med. 1998;158(13):1395-1396.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
TGF-{beta} and atherosclerosis in man
Grainger
Cardiovasc Res 2007;74:213-222.
ABSTRACT
| FULL TEXT
Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status
Jousilahti et al.
J. Epidemiol. Community Health 2003;57:730-733.
ABSTRACT
| FULL TEXT
Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post-menopausal women
Yilmazer et al.
Hum Reprod 2003;18:1531-1535.
ABSTRACT
| FULL TEXT
Immunoglobulins, C3, and the Risk of Myocardial Infarction
Muscari et al.
Arch Intern Med 1999;159:2364-2365.
FULL TEXT
Atherosclerosis and the Immune System
Niculescu and Rus
Arch Intern Med 1999;159:315-315.
FULL TEXT
Atherosclerosis and the Immune System
Bittner
Arch Intern Med 1998;158:1395-1396.
FULL TEXT
|
